Liver cell adenoma and liver cell adenomatosis

HPB

Volumn 7, Issue 3, 2005, Pages 186-196

  Barthelmes, Ludger ^a   Tait, Iain S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Liver cell adenomatosis; Liver cell adenomia

Indexed keywords

CLOMIFENE; DANAZOL; METHYLTESTOSTERONE; ORAL CONTRACEPTIVE AGENT;

ADENOMATOSIS; BLEEDING; CLINICAL PRACTICE; DRUG USE; HEPATOGRAPHY; HUMAN; LAPAROSCOPY; LIVER ADENOMA; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; MALIGNANT TRANSFORMATION; PATIENT MONITORING; PUBLISHING; REVIEW; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 27544433898     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1080/13651820510028954     Document Type: Review

References (120)

1. Flejou JF, Barge J, Menu Y, Degott C, Bismuth H, Potet F, Benhamou JP. Liver adenomatosis. An entity distinct from liver adenoma? Gastroenterology 1985;89(5):1132-8.
2. Wittekind C. Hepatocellular carcinoma and cholangiocarcinoma. In: Hermanek P, Gospodarowicz MK, Henson DE, et al., editors. Prognostic factors in cancer. Berlin: Springer; 1995. p 88-93.
3. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW. Epidemiology of hepatocellular adenoma - the role of oral contraceptive use. JAMA 1979;242(7):644-8.
4. Heinemann LA, Weimann A, Gerken G, Thiel C, Schlaud M, Do Minh T. Modern oral contraceptive use and benign liver tumors: the German benign liver tumor-case control study. Eur J Contracept Reprod Health Care 1998;3:194-200.
5. Edmondson HA. Tumors of the liver and intrahepatic bile ducts. Section 7, fascicle 25, Atlas of Tumor Pathology. Washington: Armed Forces Institute of Pathology; 1958.
6. Baum JK, Holtz F, Bookstein JJ, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973;2:926-9.
7. Klatskin G. Hepatic tumors: possible relationship to use of oral contraceptives. Gastroenterology 1977;73:386-94.
8. Horvath E, Kovacs K, Ross RC. Benign hepatoma in a young woman on contraceptive steroids. Lancet 1974;1:357-8.
9. Edmonson HA, Henderson B, Benton B. Liver cell adenomas association with use of oral contraceptives. N Engl J Med 1976;294:470-2.
10. Nime F, Pickren JW, Vana J, Aronoff BL, Baker HW, Murphy GP. The histology of liver tumors in oral contraceptive users observed during a national survey by the American College of Surgeons Commission on Cancer. Cancer 1979;44(4):1481-9.
11. Rosenberg L. The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 1991; 43(6):643-52.
12. Kawakatsu M, Vilgrain V, Erlinger S, Nahum H. Disappearance of liver cell adenoma: CT and MR imaging. Abdom Imaging 1997;22(3):274-6.
13. Marks WH, Thompson N, Appleman H. Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma. Ann Surg 1988;208(2):190-5.
14. Tesluk H, Lawrie J. Hepatocellular adenoma: Its transformation to carcinoma in a user of oral contraceptives. Arch Path Lab Med 1981;105(6):296-9.
15. Gordon SC, Reddy KR, Livingstone AS, Jeffers LJ, Schiff ER. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma. Ann Int Med 1986;105(4):547-9.
16. Carrasco D, Barrachina M, Prieto M, Berenguer J. Clomiphene citrate and liver-cell adenoma. N Engl J Med 1984;310(7):1120-1.
17. Coombes GB, Reiser J, Paradinas FJ, Burn I. An androgen-associated hepatic adenoma in a trans-sexual. Brit J Surg 1978;65(2):869-70.
18. Fermand JP, Levy Y, Bouscary D, D'Agay MF, Clot P, Frija J, Brouet JC. Danazol-induced hepatocellular adenoma. Am J Med 1990;88(5):529-30.
19. Beuers U, Richter WO, Ritter MM, Wiebecke B, Schwandt P. Klinefelter's syndrome and liver adenoma. J Clin Gastroenterol 1991;13(2):214-6.
20. Alshak NS, Cocjin J, Podesta L, van de Velde R, Makowka L, Rosenthal P, Geller SA. Hepatocellular adenoma in glycogen storage disease type IV. Arch Path Lab Med 1994; 118(1):88-91.
21. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Ped Gastroenterol Nutr 1997;24(3):276-9.
22. Bala S, Wunsch PH, Ballhausen WG. Childhood hepatocellular adenoma in familial adenomatous polyposis: mutations in adenomatous polyposis coli gene and p53. Gastroenterology 1997;112(3):919-22.
23. Libbrecht L, De Vos R, Cassiman D, Desmet V, Aerts R, Roskams T. Hepatic progenitor cells in hepatocellular adenomas. Am J Surg Path 2001;25(11):1388-96.
24. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208(5):558-64.
25. Foster JH, Berman MM. The malignant transformation of liver cell adenomas. Arch Surg 1994;129(7):712-7.
26. Chiche L, Dao T, Salame E, Galais MP, Bouvard N, Schmutz G, Rousselot P, et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000;231(1):74-81.
27. Grazioli L, Federle MP, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients. Radiology 2000; 216(2):395-402.
28. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, Fagniez PL, et al. Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22(6):1674-81.
29. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, et al. Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21(9):983-90.
30. Golli M, Van Nhieu JT, Mathieu D, Zafrani ES, Cherqui D, Dhumeaux D, Vasile N, et al. Hepatocellular adenoma: color Doppler US and pathologic correlations. Radiology 1994; 190(3):741-4.
31. Van Hoe L, Baert AL, Gryspeerdt S, Vandenbosh G, Nevens F, Van Steenbergen W, Marchal G. Dual-phase helical CT of the liver: value of an early-phase acquisition in the differential diagnosis of noncystic focal lesions. AJR Am J Roentgenol 1997;168(5):1185-92.
32. Welch TJ, Sheedy PF, Johnson CM, Stephens DH, Charboneau JW, Brown ML, May GR, et al. Focal nodular hyperpolasia and hepatic adenoma: comparison of angiography, CT, US and scintigraphy. Radiology 1985; 156:593-5.
33. Arrive L, Flejou JF, Vilgrain V. Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 1994;193:507-12.
34. Paulson EK, McClelland JS, Washington K, Spritzer CE, Meyers WC, Baker ME. Hepatic adenoma: MR characteristics and correlation with pathological findings. Am J Roentgenol 1994;163:113-6.
35. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y, Blumgart LH. Management of 155 patients with benign liver tumours. Brit J Surg 2001;88(6):808-13.
36. Pryvor AC, Cohen RJ, Goldman RL. Hepatocellular carcinoma in a woman on long-term oral contraceptives. Cancer 1977;40:884-8.
37. Korula J, Yellin A, Kanel G, Campofiori G, Nichols P. Hepatocellular carcinoma coexisting with hepatic adenoma. Incidental discovery after long-term oral contraceptive use. West J Med 1991;155:416-8.
38. Ferrell LD. Hepatocellular carcinoma arising in a focus of multilobular adenoma. Am J Surg Pathol 1993;17(5): 525-9.
39. Herman P, Machado MAC, Volpe P, Pugliese V, Vianna MR, Bacchella T, Machado MCC, et al. Transformacão de adenoma hepático em carcinoma hepatocelular em pacientes com uso prolongado de contraceptivo oral. Rev Hosp Clin Fac Med S Paulo 1994; 49(1):31-4.
40. Katkhouda N, Hurwitz M, Gugenheim J, Mavor E, Mason RJ, Waldrep DJ, Rivera RT, et al. Laparoscopic management of benign solid and cystic lesions of the liver. Ann Surg 1999;229(4):460-6.
41. Scott FR, el-Refaie A, More L, Scheuer PJ, Dhillon AP. Hepatocellular carcinoma arising in an adenoma: value of QBend 10 immunostaining in diagnosis of liver cell carcinoma. Histopathology 1996;28(5):472-4.
42. Brunt EM, Swanson PE. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant disease of the liver. Am J Clin Pathol 1992;97(5 Suppl 1):S53-61.
43. Wilkens L, Bredt M, Flemming P, Becker T, Kubicka S, Kreipe H. Differentiation of liver cell adenomata from well differentiated hepatocellular carcinomas by comparative genomic hybridisation. J Pathol 2001;193:476-82.
44. Wilkens L, Bredt M, Flemming P, Becker T, Mengel M, von Wasiliewski R, Klempnauer J, et al. Diagnostic impact of fluorescence in situ hybridization in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Mol Diag 2001;3:68-73.
45. Adusumilli PS, Lee B, Parekh K, Dolgopolov S. Hemoperitoneum from spontaneous rupture of a liver cell adenoma in a male with hyperthyroidism. Am Surg 2002;68(7):582-3.
46. Heeringa B, Sardi A. Bleeding hepatic adenoma: expectant treatment to limit the amount of liver resection. Am Surg 2001;67(10):927-9.
47. Bein NN, Goldsmith HS. Recurrent massive haemorrhage from benign hepatic tumours secondary to oral contraceptives. Br J Surg 1977;(64):433-5.
48. Contostavlos DL. Benign hepatomas and oral contraceptives. Lancet 1973;24:1200.
49. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Tilanus HW, Ijzermans JN. Treatment of ruptured hepatocellular adenoma. Brit J Surg 2001;88(2):207-9.
50. Flowers BF, McBurney RP, Vera SR. Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg 1990;56(6):380-3.
51. Minami Y, Kudo M, Kawasaki T, Chung H, Matsui S, Kitano M, Suetomi Y, et al. Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: A case report. Hepat Res 2002;23(2):145-51.
52. Terkivatan T, De Wilt JHW, De Man RA, Ijzermans JNM. Management of hepatocellular adenoma during pregnancy. Liver 2000;20(2):186-7.
53. Bis KA, Waxman G. Rupture of the liver associated with pregnancy: a review of the literature and report of two cases. Obstet Gynecol Surv 1976;31:763-73.
54. Hayes D, Lamki H, Hunter IW. Hepatic-cell adenoma presenting with intraperitoneal haemorrhage in the puerperium. Br Med J 1977;26:1394.
55. Monks PL, Fryar BG, Biggs WW. Spontaneous rupture of an hepatic adenoma in pregnancy with survival of mother and fetus. Aust N Z J Obstet Gynaecol 1986;26:155-7.
56. Rosel H D, Baier A, Mesewinkel F. Exsanguination caused by liver cell adenoma and rupture of the hepatic capsule as cause of maternal death. Zentralbl Gynäkol 1990; 112:1363-7.
57. Estebe JP, Malledant Y, Giullont YM. Rupture spontane d'un adénome du foie pendant la grossesse. J Chir 1988; 125:654-6.
58. Tsang V, Halliday AW, Collier N, Benjamin IS, Blumgart I. Hepatic cell adenoma: spontaneous rupture during pregnancy. Dig Surg 1989;6:86-7.
59. Rosales J, Avila E, Orrego M, Cajas AM, Zolezzi A. Hepatic adenoma rupture as a cause of bleeding in the third trimester of pregnancy: report of a case and review of the literature. Rev Gastroenterol Peru 2001;21(4):312-5.
60. Ault GT, Wren SM, Ralls PW, Reynolds TB, Stain SC. Selective management of hepatic adenomas. Am Surg 2001 Oct;67(10):927-9.
61. Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Dig Surg 2002;19:109-13.
62. Davis M, Portmann B, Searle M, Wright R, Williams R. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives. Br Med J 1975;4:496-8.
63. Gyorffy EJ, Bredfeldt JE, Black WC. Transformation of hepatic cell adenoma to hepatocellular carcinoma due to oral contraceptive use. Ann Int Med 1989;110:489-90.
64. Perret AG, Mosnier JF, Porcheron J, Cuilleron M, Berthoux P, Boucheron S, Audigier JC. Role of oral contraceptives in the growth of a multilobular adenoma associated with a hepatocellular carcinoma in a young woman. J Hepatol 1996;25:976-9.
65. Ye MQ, Suriawinata A, Haim MB, Parsons R, Schwartz ME. A 42 year old woman with liver masses and long term use of oral contraceptives. Semin Liv Dis 1999; 19(3):339-44.
66. Tannapfel A, Wittekind C. Präneoplasien der Leber. Pathologe 2001;22:399-406.
67. [Anonymous]. Terminology of nodular hepatocellular lesions - International working party. Hepatol 1995; 22(3):983-93.
68. Weil R 3rd, Koep LJ, Starzl TE. Liver resection for hepatic adenoma. Arch Surg 1979;114(2):178-80.
69. Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF 2nd. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983;84(5):994-1002.
70. Belghiti J, Pateron D, Panis Y, Vilgrain V, Flejou JF, Benhamou JP, Fekete F. Resection of presumed benign liver tumours. Brit J Surg 1993;80(3):380-3.
71. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995;19(1):13-8.
72. De Carlis L, Pirotta V, Rondinara GF, Sansalone CV, Colella G, Maione G, Slim AO, et al. Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liv Transpl Surg 1997;3(2):160-5.
73. Ichikawa T, Federle MP, Grazioli L, Nalesnik M. Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 2000;214(3):861-8.
74. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, Badalamenti S, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome. Am Surg 2001;67(2):173-8.
75. Charny CK, Jarnagin WR, Schwartz LH, Frommeyer HS, DeMatteo RP, Fong Y, et al. Management of 155 patients with benign liver tumours. Brit J Surg 2001; 88(6):808-13.
76. Tao LC. Are oral contraceptive-associated liver cell adenomas premalignant? Acta cytol 1992;36(3):338-44.
77. Loeb KR, Loeb LA. Significance of multiple mutations in cancer. Carcinogenesis 2000;21(3):379-85.
78. Brunt EM, Swanson PE. Immunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver. Am J Clin Path 1992;97(5 Suppl 1):S53-61.
79. Ding SF, Jalleh RP, Wood CB, Bowles L, Delhanty JD, Dooley J, Habib NA. Different DNA changes in primary and recurrent hepatocellular carcinoma. Gut 1992; 33(10):1433-5.
80. Nasarek A, Werner M, Nolte M, Klempnauer J, Georgii A. Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study. Virchows Arch A Pathol Anat Histol 1995; 427(4):373-8.
81. Gaffey MJ, Iezzoni JC, Weiss LM. Clonal analysis of focal nodular hyperplasia of the liver. Am J Path 1996; 148(4):1089-96.
82. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997;26(4):891-5.
83. Strassburg CP, Oldhafer K, Manns MP, Tukey RH. Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol 1997;52(2):212-20.
84. D'Errico A, Deleonardi G, Fiorentino M, Scoazec JY, Grigioni WF. Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma. Diagn Mol Path 1998;7(6):289-94.
85. de Boer CJ, van Krieken JH, Janssen-van Rhijn CM, Litvinov SV. Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J Pathol 1999; 188(2):201-6.
86. Tannapfel A, Busse C, Geißler F, Wizigmann H, Hauss J, Wittekind C. INK4a-ARF alterations in liver cell adenoma. Gut 2002;51(2):253-8.
87. Takayasu H, Motoi T, Kanamori Y, Kitano Y, Nakanishi H, Tange T, Nakagawara A, Hashizume K. Two case reports of childhood liver cell adenomas harboring β-catenin abnormalities. Hum Pathol 2002; 33(8):852-5.
88. Torbenson M, Lee HJ, Choti M, Gage W, Abraham S, Montgomery E, Boitnott J, Wu TT. Hepatic adenomas: Analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 2002;15(3):189-96.
89. Chen YJ, Chen PJ, Lee MC, Yeh SH, Hsu MT, Lin CH. Chromosomal analysis of hepatic adenoma and focal nodular hyperplasia by comparative genomic hybridization. Genes chromosomes cancer 2002;35:138-43.
90. Andersen PH, Packer JT. Hepatic adenoma - observations after estrogen withdrawal. Arch Surg 1976;111:898-900.
91. Aseni P, Sansalone CV, Sammartino C, Benedetto FD, Carrafiello C, Giacomoni A, Osio C, et al. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol 2001;33(3):234-6.
92. Steinbrecher UP, Lisbona R, Huang SN, Mishkin S. Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 1981; 26(11):1045-50.
93. Bühler H, Pirovino M, Akovbiantz A, Altorfer J, Weitzel M, Maranta E, Schmid M. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982;82:775-82.
94. Edmondson HA, Reynolds TB, Henderson B, Benton B. Regression of liver cell adenomas associated with oral contraceptives. Ann Int Med 1977;86:180-2.
95. Ramseur WL, Cooper MR. Asymptomatic liver cell adenomas: another case of resolution after discontinuation of oral contraceptive use. JAMA 1978;239:1647-8.
96. Heeringa B, Armando S. Bleeding hepatic adenoma: expectant treatment to limit the extent of liver resection. Am Surg 2001;67(10):927-9.
97. Kay S. Nine year follow-up of a case of benign liver cell adenoma related to oral contraceptives. Cancer 1977; 40:1759-60.
98. Mariani AF, Livingstone AS, Pereiras RV Jr. Progressive enlargement of a hepatic cell adenoma. Gastroenterology 1979;77:1319-25.
99. Marks WH, Thompson N, Appleman H. Failure of hepatic adenomas to regress after discontinuance of oral contraceptives. Ann Surg 1988;208(2):190-5.
100. Cohen C, Lawson D, DeRose PB. Sex and androgenic steroid receptor expression in hepatic adenomas. Hum Path 1998;29(12):1428-32.
101. Torbenson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, et al. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol 2002;15(3):189-96.
102. Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liv Transpl Surg 1998; 4(5):388-98.
103. Bertrand G, Saint-Andre JP, Simard C, Pillet J, Sulzer J. Letter: Nodular liver hyperplasia after oral contraception 2 new cases. Nouv Presse Med 1975;4(31):2276.
104. Leborgne J, Lehur PA, Horeau JM, Dupas B, Bourcheix LM, Petiot JM, Cloarec D, et al. Therapeutic problems caused by rupture of large hepatic adenoma with central location. Apropos of 3 cases. Chirurgie 1990;116(4-5): 454-60.
105. Khan SS, Fink M, King S. Case report: liver adenomatosis presenting as multiple calcified masses. Clin Radiol 1992; 45(3):206-7.
106. Brander WL, Vosnides G, Ogg CS, West IE. Multiple hepatocellular tumours in a patient treated with oral contraceptives. Virchows Arch A Pathol Anat Histol 1976; 370(1):69-76.
107. Dereuri O, Guilhoi JJ. Multifocal hepatocellular carcinoma presenting as prurigo: two cases. Br J Dermat 2000; 143:1319-59.
108. Yunta PJ, Moya A, San-Juan F, Lopez-Andujar R, De Juan M, Orbis F, Mir J. A new case of hepatic adenomatosis treated with orthotopic liver transplantation. Ann Chir 2001; 126(7):672-4.
109. Mueller J, Keeffe EB, Esquivel CO. Liver transplantation for treatment of giant hepatocellular adenomas. Liv Transpl Surg 1995;1(2):99-102.
110. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology 1994;20:33-40S.
111. Adam R, Cailliez V, Majno P, Karam V, McKaster P, Calne RY, O'Grady J, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000;356:621-7.
112. Haagsma EB, Hagens VE, Schaapveld M, van den Berg AP, de Vries EGE, Klompmaker IJ, Slooff MJH, et al. Increased cancer risk after liver transplantation: A population-based study. J Hepatol 2001;34(1):84-91.
113. Cohen AJ, Stegall MD, Rosen CB, Wiesner RH, Leung N, Kremers WK, Zein NN. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002;8(10):916-21.
114. Gonwa TA. Hypertension and renal dysfunction in long-term liver transplant recipients. Liver Transpl 2001;7(1):S22-S26.
115. Testa G, Malago M, Nadalin S, Paul A, Frilling A, Broelsch CE. Complications and outcomes in adult living donor liver transplantation. Curr Opin Org Transpl 2001;6(4):367-70.
116. Ramji A, Yoshida EM, Bain VG, Kneteman NM, Scudamore CH, Ma MM, Steinbrecher UP, et al. Late acute rejection after liver transplantation: The Western Canada experience. Liver Transpl 2002;8(10):945-51.
117. Neumann UP, Langrehr JM, Neuhaus P. Chronic rejection after human liver transplantation. Graft 2002;5(2):102-7.
118. Penna C. Femme de 57 ans qui presente des 'nodules' du foie. J Chir 2002;139:40-5.
119. Tepetes K, Selby R, Webb R, Madariaga JR, Iwatsuki S, Starzl TE. Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 1995;130:153-6.
120. Chiappa A, Zbar A, Audisio R, Di Palo S, Bertani E, Staudacher C. Ruptured hepatic adenoma in liver adenomatosis - A case report of emergency surgical management. Hepatogastroenterology 1999;46:1942-3.